These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 17006919

  • 1. Significance of circulating endothelial progenitor cells in hepatocellular carcinoma.
    Ho JW, Pang RW, Lau C, Sun CK, Yu WC, Fan ST, Poon RT.
    Hepatology; 2006 Oct; 44(4):836-43. PubMed ID: 17006919
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA, Gadelhak SA, El-Morsi DA, Abdelaziz MM, Abbas AT, El-Emshaty HM.
    Hepatogastroenterology; 2009 Oct; 56(94-95):1417-24. PubMed ID: 19950803
    [Abstract] [Full Text] [Related]

  • 3. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
    Poon RT, Lau C, Pang R, Ng KK, Yuen J, Fan ST.
    Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
    [Abstract] [Full Text] [Related]

  • 4. Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma.
    Sieghart W, Fellner S, Reiberger T, Ulbrich G, Ferlitsch A, Wacheck V, Peck-Radosavljevic M.
    Dig Liver Dis; 2009 Dec; 41(12):902-6. PubMed ID: 19501032
    [Abstract] [Full Text] [Related]

  • 5. Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma.
    Jeng KS, Sheen IS, Tsai YC.
    Arch Surg; 2004 Oct; 139(10):1055-60. PubMed ID: 15492142
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma.
    Poon RT, Ho JW, Tong CS, Lau C, Ng IO, Fan ST.
    Br J Surg; 2004 Oct; 91(10):1354-60. PubMed ID: 15376182
    [Abstract] [Full Text] [Related]

  • 7. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma.
    Tamesa T, Iizuka N, Mori N, Okada T, Takemoto N, Tangoku A, Oka M.
    Hepatogastroenterology; 2009 Oct; 56(93):1122-6. PubMed ID: 19760954
    [Abstract] [Full Text] [Related]

  • 8. Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma.
    Cheng KS, Tang HL, Chou FT, Chou JW, Hsu CH, Yu CJ, Kao ST, Li TC.
    Hepatogastroenterology; 2009 Oct; 56(93):1105-10. PubMed ID: 19760951
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis.
    Ren Y, Poon RT, Tsui HT, Chen WH, Li Z, Lau C, Yu WC, Fan ST.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5996-6001. PubMed ID: 14676125
    [Abstract] [Full Text] [Related]

  • 10. Differential vascular endothelial growth factor A protein expression between small hepatocellular carcinoma and cirrhosis correlates with serum vascular endothelial growth factor A and alpha-fetoprotein.
    Corradini SG, Morini S, Liguori F, Carotti S, Muda AO, Burza MA, Siciliano M, Molinaro A, Cantafora A, Blotta I, Merli M, Berloco P, Rossi M, Attili AF, Gaudio E.
    Liver Int; 2009 Jan 01; 29(1):103-12. PubMed ID: 18544126
    [Abstract] [Full Text] [Related]

  • 11. Circulating endothelial progenitor cells in patients with ANCA-associated vasculitis.
    Závada J, Kideryová L, Pytlík R, Vanková Z, Tesar V.
    Kidney Blood Press Res; 2008 Jan 01; 31(4):247-54. PubMed ID: 18600027
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma.
    Cillo U, Navaglia F, Vitale A, Molari A, Basso D, Bassanello M, Brolese A, Zanus G, Montin U, D'Amico F, Ciarleglio FA, Carraro A, Bridda A, Burra P, Carraro P, Plebani M, D'Amico DF.
    Clin Chim Acta; 2004 Sep 01; 347(1-2):129-38. PubMed ID: 15313150
    [Abstract] [Full Text] [Related]

  • 13. Serum alpha-fetoprotein level per tumor volume reflects prognosis in patients with hepatocellular carcinoma after curative hepatectomy.
    Furihata T, Sawada T, Kita J, Iso Y, Kato M, Rokkaku K, Shimoda M, Kubota K.
    Hepatogastroenterology; 2008 Sep 01; 55(86-87):1705-9. PubMed ID: 19102374
    [Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor monitoring in advanced hepatocellular carcinoma patients treated with radiofrequency ablation plus octreotide: a single center experience.
    Montella L, Addeo R, Caraglia M, Faiola V, Guarrasi R, Vincenzi B, Palmeri A, Capasso E, Nocera V, Tarantino L, Ariete M, Martorelli A, Del Prete S.
    Oncol Rep; 2008 Aug 01; 20(2):385-90. PubMed ID: 18636202
    [Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma.
    Zhao J, Hu J, Cai J, Yang X, Yang Z.
    Chin Med J (Engl); 2003 May 01; 116(5):772-6. PubMed ID: 12875699
    [Abstract] [Full Text] [Related]

  • 16. Circulating platelet-derived endothelial cell growth factor increases in hepatocellular carcinoma patients.
    Jin-no K, Tanimizu M, Hyodo I, Nishikawa Y, Hosokawa Y, Endo H, Doi T, Mandai K, Ishitsuka H.
    Cancer; 1998 Apr 01; 82(7):1260-7. PubMed ID: 9529017
    [Abstract] [Full Text] [Related]

  • 17. Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity.
    Avouac J, Juin F, Wipff J, Couraud PO, Chiocchia G, Kahan A, Boileau C, Uzan G, Allanore Y.
    Ann Rheum Dis; 2008 Oct 01; 67(10):1455-60. PubMed ID: 18174219
    [Abstract] [Full Text] [Related]

  • 18. Elevation of transforming growth factor alpha and its relationship to the epidermal growth factor and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
    Yeh YC, Tsai JF, Chuang LY, Yeh HW, Tsai JH, Florine DL, Tam JP.
    Cancer Res; 1987 Feb 01; 47(3):896-901. PubMed ID: 2433030
    [Abstract] [Full Text] [Related]

  • 19. Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma.
    Uematsu S, Higashi T, Nouso K, Kariyama K, Nakamura S, Suzuki M, Nakatsukasa H, Kobayashi Y, Hanafusa T, Tsuji T, Shiratori Y.
    J Gastroenterol Hepatol; 2005 Apr 01; 20(4):583-8. PubMed ID: 15836707
    [Abstract] [Full Text] [Related]

  • 20. Decreased small arterial compliance with increased serum vascular endothelial growth factor-A and circulating endothelial progenitor cell in dilated cardiomyopathy.
    Zhou YL, Li XL, Zhang HF, Yao WM, Tong M, Xu Q, Cao KJ, Huang J.
    Chin Med J (Engl); 2008 Feb 20; 121(4):316-20. PubMed ID: 18304463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.